McKinsey & Company

Putting innovation—and patients—in focus: A conversation with Astellas Pharma CEO Naoki Okamura

The Tokyo-based biopharmaceutical company is accelerating its pipeline by innovating at the intersection of biology, modality, and disease.

作者 McKinsey & Company

1 分钟阅读

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Strategy & Innovation相关内容

相关洞察